ArticleVeterinary research2026
Modification of PCNA by ISG15 plays a crucial role in porcine deltacoronavirus infection.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Porcine deltacoronavirus (PDCoV), an emerging enteropathogenic coronavirus belonging to the deltacoronavirus genus, has caused massive losses to the livestock industry and poses a potential risk of cross-species transmission. Interferon-stimulated gene 15 (ISG15) plays a crucial role in virus infection and immune regulation through interactions with cellular and viral proteins. However, the mechanisms underlying the effect of ISG15 on PDCoV infection are poorly understood. In this study, we demonstrated that the knockout of ISG15, mediated by CRISPR-Cas9, facilitates PDCoV replication and that ISG15 modification (ISGylation) deficiency attenuates the antiviral ability of ISG15. To clarify the novel roles of ISG15 during PDCoV infection, we constructed a stable ISG15-overexpressed IPEC-J2 cell line. We employed tandem affinity purification followed by mass spectrometry analyses with ISG15, enabling the identification of 538 known and novel candidate ISGylation proteins including proliferating cell nuclear antigen (PCNA) which is a sign of DNA damage. We showed that ISGylation of PCNA significantly inhibited PDCoV replication. During PDCoV infection, HERC5, an ISG15 E3 ligase, interacted with PCNA and promoted its ISGylation, whereas USP18 eventually de-ISGylated PCNA. Our results not only reveal that ISGylation acts as a post-translational modification of PCNA but also elucidate the function of ISGylation in PCNA during PDCoV infection, thereby adding a novel layer of complexity to the virus-host interaction interface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.